Abadies, Concheta M.
HRN: 20-06-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/15/2024
06/22/2024
IV
1.5g
Q8
Cellulitis R Elbow
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes